This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Mar;88(2):151-4.

doi: 10.1016/S1472-9792(08)70024-6.

Rifampin

No authors listed

PMID: 18486058
DOI: 10.1016/S1472-9792(08)70024-6

Review

Rifampin

No authors listed. Tuberculosis (Edinb). 2008 Mar.

. 2008 Mar;88(2):151-4.

doi: 10.1016/S1472-9792(08)70024-6.

PMID: 18486058
DOI: 10.1016/S1472-9792(08)70024-6

No abstract available

PubMed Disclaimer

Similar articles

Rifapentine.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):155-8. doi: 10.1016/S1472-9792(08)70025-8. Tuberculosis (Edinb). 2008. PMID: 18486059 Review. No abstract available.
Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG, Lötter AP. Dekker TG, et al. Int J Tuberc Lung Dis. 2003 Mar;7(3):205-6. Int J Tuberc Lung Dis. 2003. PMID: 12661831 No abstract available.
Rifalazil.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):148-50. doi: 10.1016/S1472-9792(08)70023-4. Tuberculosis (Edinb). 2008. PMID: 18486057 Review. No abstract available.
Rifabutin.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):145-7. doi: 10.1016/S1472-9792(08)70022-2. Tuberculosis (Edinb). 2008. PMID: 18486056 Review. No abstract available.
Cycloserine.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):100-1. doi: 10.1016/S1472-9792(08)70007-6. Tuberculosis (Edinb). 2008. PMID: 18486041 Review. No abstract available.

See all similar articles

Cited by

The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
Namasivayam S, Sher A, Glickman MS, Wipperman MF. Namasivayam S, et al. mBio. 2018 Sep 18;9(5):e01420-18. doi: 10.1128/mBio.01420-18. mBio. 2018. PMID: 30228238 Free PMC article. Review.
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.
Saini V, Ammerman NC, Chang YS, Tasneen R, Chaisson RE, Jain S, Nuermberger E, Grosset JH. Saini V, et al. Antimicrob Agents Chemother. 2019 May 24;63(6):e00388-19. doi: 10.1128/AAC.00388-19. Print 2019 Jun. Antimicrob Agents Chemother. 2019. PMID: 30936097 Free PMC article.
Comprehensive Therapeutic Approaches to Tuberculous Meningitis: Pharmacokinetics, Combined Dosing, and Advanced Intrathecal Therapies.
Madadi AK, Sohn MJ. Madadi AK, et al. Pharmaceutics. 2024 Apr 14;16(4):540. doi: 10.3390/pharmaceutics16040540. Pharmaceutics. 2024. PMID: 38675201 Free PMC article. Review.
Permeation Challenges of Drugs for Treatment of Neurological Tuberculosis and HIV and the Application of Magneto-Electric Nanoparticle Drug Delivery Systems.
Mhambi S, Fisher D, Tchokonte MBT, Dube A. Mhambi S, et al. Pharmaceutics. 2021 Sep 15;13(9):1479. doi: 10.3390/pharmaceutics13091479. Pharmaceutics. 2021. PMID: 34575555 Free PMC article. Review.
Extrapulmonary and Drug-Resistant Childhood Tuberculosis: Unveiling the Disease to Adopt the Optimal Treatment Strategy.
Pace D, Corvaglia F, Lisi C, Galli L, Chiappini E. Pace D, et al. Pathogens. 2023 Dec 12;12(12):1439. doi: 10.3390/pathogens12121439. Pathogens. 2023. PMID: 38133322 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information